Diagnosis and Treatment of Scattered Itchy Circular Lesions with Central Clearance
The most likely diagnosis is tinea corporis (ringworm), which should be treated with topical antifungal therapy as first-line management. 1
Clinical Diagnosis
The presentation of pruritic, annular (circular), erythematous lesions with central clearing that grow centrifugally is pathognomonic for tinea corporis. 1 This fungal infection characteristically presents as scattered macules and papules with the distinctive ring-shaped appearance and central clearing described. 1
Diagnostic Confirmation
- Perform potassium hydroxide (KOH) examination of skin scrapings from the active border of lesions to confirm fungal elements before initiating treatment. 1
- The active, raised border contains the highest concentration of fungal organisms, making it the optimal site for sampling. 1
Key Differential Diagnoses to Consider
While tinea corporis is most likely, other conditions with annular presentations include:
- Erythema multiforme: Presents with target lesions but typically has minimal pruritus and involves distal extremities preferentially. 2
- Nummular eczema: Shows coin-shaped papulovesicular lesions but lacks the characteristic advancing border with central clearing. 1
- Granuloma annulare: Non-pruritic annular lesions, which distinguishes it from the itchy presentation described. 1
- Pityriasis rosea: Multiple erythematous lesions with raised, scaly borders but generally self-limited and often preceded by a herald patch. 1
Treatment Protocol
First-Line Topical Antifungal Therapy
Apply topical antifungal cream (clotrimazole, miconazole, or terbinafine) twice daily to affected areas and 2-3 cm beyond the visible border for 2-4 weeks. 1 Continue treatment for at least one week after clinical resolution to prevent recurrence.
Symptomatic Management of Pruritus
- Oral antihistamines: Cetirizine or loratadine 10 mg daily (non-sedating), or hydroxyzine 10-25 mg four times daily or at bedtime for more severe itching. 3
- Low-potency topical corticosteroids (hydrocortisone 1-2.5% cream) may be used sparingly for severe pruritus, but should not be used as monotherapy as they can worsen fungal infections. 4, 5
When to Escalate Treatment
If lesions cover >10% body surface area (BSA), consider:
- Non-urgent dermatology referral 3
- Continue topical antifungals with oral antihistamines 3
- May require systemic antifungal therapy (oral terbinafine or itraconazole) for extensive involvement
If lesions cover >30% BSA or fail to respond to topical therapy after 2-3 weeks:
- Same-day dermatology consultation 3
- Consider systemic antifungal therapy
- Rule out immunocompromised state or alternative diagnoses 3
Critical Pitfalls to Avoid
- Do not use topical corticosteroids alone without antifungal coverage, as this will worsen tinea corporis by suppressing local immunity while allowing fungal proliferation. 4
- Do not stop treatment when lesions appear resolved; continue for at least one additional week to prevent recurrence. 1
- Always confirm diagnosis with KOH preparation when possible, as misdiagnosis can lead to inappropriate treatment and disease progression. 1
- Evaluate for tinea pedis, tinea cruris, or onychomycosis as potential sources of autoinoculation requiring concurrent treatment. 1